Status:
UNKNOWN
Comparison Between Uterine Artery Doppler and Placental Vascular Indices in Prediction of Preeclampsia
Lead Sponsor:
National Research Centre, Egypt
Conditions:
Pre-Eclampsia
Eligibility:
FEMALE
18-35 years
Brief Summary
• Preeclampsia is a multisystem disorder that can cause considerable maternal and fetal morbidity and mortality. Late preeclampsia (with delivery \>34 weeks) is more frequent and less serious than ear...
Detailed Description
* The introduction of three-dimensional (3D) ultrasound techniques, with the option of calculating placental volume and measuring vascular indices, has created an excellent opportunity to study early ...
Eligibility Criteria
Inclusion
- A. Control group: Pregnant women:
- Age between 18-35 years
- Parity: primigravidas and multiparas.
- Have no history of preeclampsia or eclampsia.
- Have no history of chronic hypertension.
- Not diabetic.
- Not have antiphospholipid syndrome.
- Not have autoimmune disease such as SLE.
- B. High risk group: Pregnant women with:
- History of preeclampsia -Eclapmsia
- Chronic hypertension
- Diabetic
- Antiphospholipid syndrome.
- Autoimmune syndrome such as SLE.
Exclusion
- • Smoking
- Dichorionic placentae
- Fetal anomaly
- Uterine fibroid at the site of placental implantation
- Subchorionic hematoma
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03838887
Start Date
June 1 2021
End Date
January 1 2022
Last Update
August 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Research Centre
Cairo, Egypt, 1234